- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01102517
A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer
February 27, 2018 updated by: Hao Long, Sun Yat-sen University
The purpose of this study is to establish the effects of VATS lobectomy for early-stage non-small cell lung cancer.
The aims of this study are:
- To evaluate the early clinical benefits of VATS lobectomy when compared with the axillary thoracotomy.
- To evaluate the late effects of VATS lobectomy on survival and quality of life when compared with axillary thoracotomy.
- To establish the normative pattern of VATS lobectomy for early-stage non-small cell lung cancer.
- To explore the indication of VATS lobectomy for the lung cancer.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
500
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
GuangZhou, Guangdong, China, 510060
- Sun Yat-Sen University Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Early stage NSCLC and no metastasis of hilum of lung and mediastinum lymph nodes (short diameter ≤ 1 cm) on computed tomography (CT) scan;
- No medical contraindications to lung resection
- Age ≤ 75 years old and ≥18 years old;
- Sign the informed consent form.
Exclusion Criteria:
- Evidence of invasion into neighboring organs;
- Extensive pleura adhesion;
- Central lesion;
- Not suitable for single-lung ventilation;
- Had history of thoracotomy and radiation for thoracic region ;
- Pregnancy or lactation female patients;
- Cannot sign the informed consent form because of psychological, family and society factors;
- Had history of other malignant tumors within 5 years except for non-melanoma cutaneous cancer, uterine cervix cancer in situ and curative early-stage carcinoma of prostate;
- Participants can not accept operation for other uncontrolled factors.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VATS group
video-assisted thoracoscopic surgery
|
video-assisted thoracoscopic surgery
|
|
Other: axillary thoracotomy
Control group
|
axillary thoracotomy lobectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Disease-free survival and overall survival
Time Frame: 5 years
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life
Time Frame: the first year after the surgery
|
Lung Cancer Symptom Scale
|
the first year after the surgery
|
|
Postoperative pulmonary function
Time Frame: the first three months after the surgery
|
the first three months after the surgery
|
|
|
Postoperative Karnofsky performance status
Time Frame: the first year after the surgery
|
the first year after the surgery
|
|
|
Postoperative Chest Pain
Time Frame: the first year after the surgery
|
visual analogue scale and Wong-Baker FACES Pain Rating Scale
|
the first year after the surgery
|
|
Perioperation data
Time Frame: perioperation
|
operation time, intraoperative blood loss, chest tube drainage amount, duration of the chest tube placement, and duratio
|
perioperation
|
|
Cytokines response
Time Frame: the first 48 hours after the surgery
|
IL-2,IL-4,IL-6,IL-10,TNF,IFN-r
|
the first 48 hours after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Hao Long, professor, Sun Yat-sen University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- 1.Bethencourt DM, Holmes EC. Muscle-sparing posterolateral thoracotomy. Ann Thorac Surg. 1988;45(3):337-339. 2.Ginsberg RJ. Alternative (muscle-sparing) incisions in thoracic surgery. Ann Thorac Surg. 1993;56(3):752-754. 3.Weissberg D, Kaufman M. Technical aids in surgery. Two muscle-sparing thoracotomies--techniques and indications. S Afr J Surg. 1990;28(1):17-19. 4.Akçali Y, Demir H, Tezcan B. The effect of standard posterolateral versus muscle-sparing thoracotomy on multiple parameters. Ann Thorac Surg. 2003;76(4):1050-1054. 5.Hazelrigg SR, Landreneau RJ, Boley TM, et al. The effect of muscle-sparing versus standard posterolateral thoracotomy on pulmonary function, muscle strength, and postoperative pain. J Thorac Cardiovasc Surg. 1991;101(3):394-400. 6.Kutlu CA, Akin H, Olcmen A, et al. Shoulder-girdle strength after standard and lateral muscle-sparing thoracotomy. Thorac Cardiovasc Surg. 2001;49(2):112-114. 7.Khan IH, McManus KG, McCraith A, et al. Muscle sparing thoracotomy: a biomechanical analysis confirms preservation of muscle strength but no improvement in wound discomfort. Eur J Cardiothorac Surg. 2000;18(6):656-661. 8.Baeza OR, Foster ED. Vertical axillary thoracotomy: a functional and cosmetically appealing incision. Ann Thorac Surg. 1976;22(3):287-288.
- Long H, Tan Q, Luo Q, Wang Z, Jiang G, Situ D, Lin Y, Su X, Liu Q, Rong T. Thoracoscopic Surgery Versus Thoracotomy for Lung Cancer: Short-Term Outcomes of a Randomized Trial. Ann Thorac Surg. 2018 Feb;105(2):386-392. doi: 10.1016/j.athoracsur.2017.08.045. Epub 2017 Dec 2.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Anticipated)
December 1, 2018
Study Completion (Anticipated)
December 1, 2018
Study Registration Dates
First Submitted
April 6, 2010
First Submitted That Met QC Criteria
April 12, 2010
First Posted (Estimate)
April 13, 2010
Study Record Updates
Last Update Posted (Actual)
February 28, 2018
Last Update Submitted That Met QC Criteria
February 27, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2007039
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.